Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Abbott 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Abbott 1Q

Worldwide pharmaceutical sales were $3.6 billion (-6%). Humira sales were $1.0 billion (+17%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 1Q

1Q Revenues: $6.7 billion (-1%)

1Q Earnings: $1.4 billion(+53%)

Comments: Worldwide pharmaceutical sales were $3.6 billion (-6%).
Humira sales were $1.0 billion (+17%). Kaletra sales dropped 17% to $292 million, while Depakote sales were down 65% to $129 million due to generic competition. TriCor/Trilipix sales were $253 million (+3%). Worldwide vascular sales were $645 million (+43%) with Coronary Stent sales up 112% to $402 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters